| Drug Name | Demexa( Dexedetomidine) |
|---|---|
| Drug Class |
Central nervous system stimulant
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Neurology
|
| Risk |
Increased risk of 90-day mortality in intensive care unit (ICU) patients ≤65 years |
| Dear Healthcare provider letter DHPC |
|